Biotechnology
The Biotechnology industry has a total of 656 stocks, with a combined market cap of $854.06 billion and total revenue of $94.68 billion.
Market Cap
854.06B
Revenue
94.68B
Profits
-42.28B
PE Ratio
n/a
Profit Margin
-44.65%
Dividend Yield
0.09%
656 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.22B | 0.03% | 1,210,594 | 10.63B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.16B | -1.13% | 945,011 | 13.85B |
| 3 | ARGX | argenx SE | 39.07B | -1.17% | 216,000 | 1.91B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.38B | 0.58% | 711,268 | 2.09B |
| 5 | BNTX | BioNTech SE | 27.61B | -1.77% | 548,658 | 3.39B |
| 6 | ONC | BeiGene, Ltd. | 23.68B | 1.61% | 379,386 | 3.35B |
| 7 | RPRX | Royalty Pharma plc | 17.72B | -0.73% | 3,417,652 | 2.27B |
| 8 | SMMT | Summit Therapeutics Inc. | 17.34B | 6.43% | 4,378,589 | - |
| 9 | UTHR | United Therapeutics Corporation | 16.58B | 0.90% | 311,458 | 2.76B |
| 10 | MRNA | Moderna, Inc. | 14.82B | 7.27% | 16,592,856 | 5.08B |
| 11 | INSM | Insmed Incorporated | 14.03B | 2.22% | 1,543,818 | 342.96M |
| 12 | INCY | Incyte Corporation | 13.95B | -1.44% | 1,094,895 | 4.08B |
| 13 | GMAB | Genmab A/S | 13.39B | -3.81% | 914,049 | 2.97B |
| 14 | TECH | Bio-Techne Corporation | 12.51B | -0.05% | 988,522 | 1.17B |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 11.82B | -0.82% | 1,548,779 | 2.75B |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 11.09B | -0.60% | 640,739 | 1.64B |
| 17 | PCVX | Vaxcyte, Inc. | 10.80B | -1.74% | 1,504,090 | - |
| 18 | EXEL | Exelixis, Inc. | 9.39B | -9.74% | 3,825,958 | 2.08B |
| 19 | ROIV | Roivant Sciences Ltd. | 8.12B | -0.98% | 3,433,413 | 129.13M |
| 20 | RVMD | Revolution Medicines, Inc. | 7.56B | 1.89% | 1,202,396 | 742.00K |
| 21 | ASND | Ascendis Pharma A/S | 7.53B | -4.00% | 525,485 | 365.19M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 7.31B | -0.49% | 304,247 | 3.99B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 7.08B | 5.74% | 329,340 | 76.81M |
| 24 | BPMC | Blueprint Medicines Corporation | 7.06B | -0.79% | 711,607 | 434.42M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 7.03B | -1.18% | 1,135,791 | 947.36M |
| 26 | LEGN | Legend Biotech Corporation | 6.87B | 7.99% | 2,312,254 | 520.18M |
| 27 | BBIO | BridgeBio Pharma, Inc. | 6.77B | -0.67% | 1,808,730 | 217.77M |
| 28 | CORT | Corcept Therapeutics Incorporated | 6.18B | -3.40% | 1,321,624 | 628.56M |
| 29 | NUVL | Nuvalent, Inc. | 5.78B | 3.88% | 576,989 | - |
| 30 | TLX | Telix Pharmaceuticals Limited | 5.63B | 0.47% | 16,251 | 430.80M |
| 31 | CYTK | Cytokinetics, Incorporated | 5.53B | 2.18% | 1,318,587 | 3.22M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 5.13B | -0.55% | 946,265 | 803.07M |
| 33 | AXSM | Axsome Therapeutics, Inc. | 4.96B | 6.33% | 1,217,654 | 338.46M |
| 34 | VRNA | Verona Pharma plc | 4.47B | 2.19% | 1,115,238 | 5.62M |
| 35 | KRYS | Krystal Biotech, Inc. | 4.41B | 1.26% | 234,641 | 241.52M |
| 36 | SRRK | Scholar Rock Holding Corporation | 4.37B | 4.12% | 1,505,141 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 4.18B | -2.41% | 2,004,203 | 264.79M |
| 38 | BHVN | Biohaven Ltd. | 4.10B | 3.92% | 1,047,154 | - |
| 39 | RARE | Ultragenyx Pharmaceutical Inc. | 3.96B | 4.02% | 747,379 | 522.75M |
| 40 | ADMA | ADMA Biologics, Inc. | 3.89B | 1.92% | 2,312,315 | 382.81M |
| 41 | VKTX | Viking Therapeutics, Inc. | 3.79B | 3.59% | 4,395,242 | - |
| 42 | APLS | Apellis Pharmaceuticals, Inc. | 3.78B | 0.86% | 1,313,382 | 715.22M |
| 43 | CRSP | CRISPR Therapeutics AG | 3.77B | 6.48% | 5,337,142 | 202.83M |
| 44 | RNA | Avidity Biosciences, Inc. | 3.59B | -2.46% | 1,211,419 | 10.12M |
| 45 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.58B | -0.28% | 1,808,052 | 1.04M |
| 46 | ACLX | Arcellx, Inc. | 3.56B | -1.08% | 970,314 | 155.82M |
| 47 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.52B | -0.50% | 345,131 | 112.53M |
| 48 | PTCT | PTC Therapeutics, Inc. | 3.48B | -0.38% | 563,663 | 900.66M |
| 49 | IMVT | Immunovant, Inc. | 3.41B | -1.53% | 850,916 | - |
| 50 | DNLI | Denali Therapeutics Inc. | 3.35B | 1.17% | 1,006,094 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 2.99B | 0.54% | 169,254 | - |
| 52 | MLTX | MoonLake Immunotherapeutics | 2.97B | 2.82% | 964,735 | - |
| 53 | ACAD | ACADIA Pharmaceuticals Inc. | 2.96B | -0.45% | 898,205 | 929.24M |
| 54 | RXRX | Recursion Pharmaceuticals, Inc. | 2.95B | 8.87% | 34,789,724 | 65.18M |
| 55 | ZLAB | Zai Lab Limited | 2.90B | 2.42% | 982,971 | 355.75M |
| 56 | VCEL | Vericel Corporation | 2.89B | -1.73% | 447,188 | 226.84M |
| 57 | KYMR | Kymera Therapeutics, Inc. | 2.86B | 0.98% | 289,466 | 87.56M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 2.85B | 0.32% | 1,593,284 | 493.67M |
| 59 | MRUS | Merus N.V. | 2.78B | 2.24% | 379,076 | 35.93M |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.73B | -0.22% | 722,720 | 460.48M |
| 61 | SWTX | SpringWorks Therapeutics, Inc. | 2.60B | -3.71% | 1,590,112 | 135.49M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 2.57B | -0.91% | 1,157,881 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 2.50B | -1.39% | 745,484 | 33.59M |
| 64 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.45B | -0.25% | 980,319 | 3.55M |
| 65 | IBRX | ImmunityBio, Inc. | 2.35B | - | 5,453,757 | 7.33M |
| 66 | JANX | Janux Therapeutics, Inc. | 2.32B | -1.78% | 1,388,586 | 13.05M |
| 67 | CGON | CG Oncology, Inc. | 2.30B | 0.70% | 768,817 | 684.00K |
| 68 | MIRM | Mirum Pharmaceuticals, Inc. | 2.24B | -2.63% | 302,251 | 307.03M |
| 69 | APGE | Apogee Therapeutics, Inc. | 2.21B | -1.37% | 591,162 | - |
| 70 | HRMY | Harmony Biosciences Holdings, Inc. | 2.20B | -4.45% | 521,538 | 681.88M |
| 71 | CNTA | Centessa Pharmaceuticals plc | 2.20B | 1.34% | 160,439 | 6.85M |
| 72 | PTGX | Protagonist Therapeutics, Inc. | 2.20B | -3.20% | 522,559 | 323.80M |
| 73 | LGND | Ligand Pharmaceuticals Incorporated | 2.19B | -1.28% | 93,758 | 152.42M |
| 74 | MESO | Mesoblast Limited | 2.18B | -2.55% | 338,748 | 5.90M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.14B | 0.21% | 583,595 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.10B | 7.58% | 1,120,743 | 349.64M |
| 77 | SLNO | Soleno Therapeutics, Inc. | 2.09B | -1.51% | 292,762 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.00B | -0.04% | 579,533 | 3.92M |
| 79 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | 2.50% | 605,121 | 32.87M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 1.84B | 2.93% | 433,648 | 129.62M |
| 81 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | 1.87% | 8,322,582 | 90.86M |
| 82 | BLTE | Belite Bio, Inc | 1.82B | 1.19% | 37,079 | - |
| 83 | GERN | Geron Corporation | 1.81B | 1.01% | 5,217,322 | 29.48M |
| 84 | WVE | Wave Life Sciences Ltd. | 1.78B | 5.05% | 705,116 | 53.61M |
| 85 | AKRO | Akero Therapeutics, Inc. | 1.75B | -2.27% | 768,775 | - |
| 86 | IRON | Disc Medicine, Inc. | 1.74B | -3.34% | 721,075 | - |
| 87 | MNKD | MannKind Corporation | 1.70B | 2.15% | 2,312,301 | 267.20M |
| 88 | TVTX | Travere Therapeutics, Inc. | 1.69B | - | 1,686,060 | 203.45M |
| 89 | FTRE | Fortrea Holdings Inc. | 1.66B | -1.07% | 565,367 | 2.98B |
| 90 | CLDX | Celldex Therapeutics, Inc. | 1.61B | -1.50% | 508,469 | 9.98M |
| 91 | ARQT | Arcutis Biotherapeutics, Inc. | 1.60B | 4.82% | 1,356,187 | 138.71M |
| 92 | GPCR | Structure Therapeutics Inc. | 1.60B | -1.41% | 645,329 | - |
| 93 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.58B | 0.13% | 1,789,881 | 412.58M |
| 94 | GLPG | Galapagos NV | 1.57B | 0.42% | 105,532 | 290.09M |
| 95 | IMCR | Immunocore Holdings plc | 1.55B | 3.40% | 297,887 | 296.31M |
| 96 | PRAX | Praxis Precision Medicines, Inc. | 1.53B | 1.70% | 457,594 | 1.61M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.45B | -0.33% | 684,475 | 302.00K |
| 98 | VIR | Vir Biotechnology, Inc. | 1.45B | 1.06% | 1,162,592 | 78.62M |
| 99 | XNCR | Xencor, Inc. | 1.45B | 1.08% | 436,832 | 85.16M |
| 100 | DYN | Dyne Therapeutics, Inc. | 1.44B | -3.02% | 3,072,730 | - |
| 101 | NVAX | Novavax, Inc. | 1.41B | 0.23% | 2,811,072 | 885.19M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.39B | 0.41% | 407,301 | 56.42M |
| 103 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | 1.72% | 2,823,946 | 276.92M |
| 104 | MDXG | MiMedx Group, Inc. | 1.32B | -1.64% | 466,548 | 342.80M |
| 105 | SPRY | ARS Pharmaceuticals, Inc. | 1.32B | 0.52% | 1,102,083 | 2.57M |
| 106 | SYRE | Spyre Therapeutics, Inc. | 1.28B | -2.06% | 641,965 | - |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.26B | -1.24% | 897,842 | 61.44M |
| 108 | ARVN | Arvinas, Inc. | 1.25B | -1.88% | 908,217 | 161.10M |
| 109 | DAWN | Day One Biopharmaceuticals, Inc. | 1.25B | 1.14% | 660,737 | 101.95M |
| 110 | RCUS | Arcus Biosciences, Inc. | 1.23B | -5.23% | 884,317 | 263.00M |
| 111 | ARDX | Ardelyx, Inc. | 1.20B | 2.85% | 5,167,145 | 251.85M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.20B | 2.41% | 1,058,396 | 16.00M |
| 113 | ADPT | Adaptive Biotechnologies Corporation | 1.18B | 7.52% | 3,133,182 | 177.28M |
| 114 | LQDA | Liquidia Corporation | 1.18B | 2.42% | 1,770,833 | 15.61M |
| 115 | INVA | Innoviva, Inc. | 1.16B | -1.17% | 531,306 | 352.75M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.12B | 10.76% | 4,730,882 | 43.09M |
| 117 | AUPH | Aurinia Pharmaceuticals Inc. | 1.11B | - | 1,148,095 | 220.36M |
| 118 | RCKT | Rocket Pharmaceuticals, Inc. | 1.09B | 3.15% | 1,473,317 | - |
| 119 | ELVN | Enliven Therapeutics, Inc. | 1.08B | 0.23% | 182,617 | - |
| 120 | PHVS | Pharvaris N.V. | 1.06B | 2.20% | 55,307 | - |
| 121 | ABCL | AbCellera Biologics Inc. | 1.04B | 15.36% | 11,012,796 | 32.96M |
| 122 | ZYME | Zymeworks Inc. | 1.01B | 2.66% | 290,482 | 62.20M |
| 123 | REPL | Replimune Group, Inc. | 1.00B | 9.87% | 1,451,605 | - |
| 124 | OCS | Oculis Holding AG | 951.73M | 0.22% | 65,117 | 1.03M |
| 125 | GYRE | Gyre Therapeutics, Inc. | 918.30M | -2.37% | 51,693 | 105.03M |
| 126 | BCYC | Bicycle Therapeutics plc | 911.41M | -2.65% | 287,832 | 36.90M |
| 127 | COGT | Cogent Biosciences, Inc. | 905.79M | - | 998,063 | - |
| 128 | AVBP | ArriVent BioPharma, Inc. | 897.36M | 5.22% | 184,763 | - |
| 129 | NUVB | Nuvation Bio Inc. | 891.90M | 2.71% | 2,154,500 | 2.16M |
| 130 | CVAC | CureVac N.V. | 888.28M | -4.35% | 635,158 | 70.57M |
| 131 | SEPN | Septerna, Inc. | 860.53M | 3.64% | 146,467 | 981.00K |
| 132 | AVXL | Anavex Life Sciences Corp. | 847.31M | 1.42% | 1,127,979 | - |
| 133 | TYRA | Tyra Biosciences, Inc. | 831.13M | -0.69% | 242,015 | - |
| 134 | RLAY | Relay Therapeutics, Inc. | 823.52M | 5.58% | 2,234,915 | 10.01M |
| 135 | CDMO | Avid Bioservices, Inc. | 796.34M | -0.08% | 1,888,728 | 150.45M |
| 136 | ETNB | 89bio, Inc. | 793.68M | 2.58% | 711,709 | - |
| 137 | SANA | Sana Biotechnology, Inc. | 781.44M | 19.86% | 14,076,986 | - |
| 138 | PRTA | Prothena Corporation plc | 776.46M | 2.27% | 323,933 | 133.35M |
| 139 | CRMD | CorMedix Inc. | 746.33M | -1.52% | 834,507 | 12.26M |
| 140 | QURE | uniQure N.V. | 745.28M | 2.55% | 545,644 | 28.59M |
| 141 | OPT | Opthea Limited | 698.35M | -0.45% | 42,405 | 261.86K |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 696.50M | -1.30% | 279,833 | - |
| 143 | DNA | Ginkgo Bioworks Holdings, Inc. | 684.76M | 11.40% | 1,972,182 | 217.95M |
| 144 | CAPR | Capricor Therapeutics, Inc. | 677.50M | 5.97% | 1,179,799 | 23.23M |
| 145 | LENZ | LENZ Therapeutics, Inc. | 672.67M | 2.69% | 138,657 | - |
| 146 | DNTH | Dianthus Therapeutics, Inc. | 670.67M | 4.62% | 164,635 | 5.37M |
| 147 | PLRX | Pliant Therapeutics, Inc. | 664.52M | -1.36% | 607,268 | - |
| 148 | VERV | Verve Therapeutics, Inc. | 660.38M | 18.72% | 4,282,866 | 24.40M |
| 149 | IMTX | Immatics N.V. | 650.49M | 0.93% | 1,329,838 | 128.82M |
| 150 | BCAX | Bicara Therapeutics Inc. | 648.63M | -1.32% | 255,305 | - |
| 151 | IMNM | Immunome, Inc. | 637.28M | 0.39% | 519,566 | 10.13M |
| 152 | TECX | Tectonic Therapeutic, Inc. | 619.61M | 1.50% | 154,818 | - |
| 153 | PHAR | Pharming Group N.V. | 613.63M | -7.90% | 8,944 | 285.75M |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 611.97M | 0.86% | 356,357 | - |
| 155 | EYPT | EyePoint Pharmaceuticals, Inc. | 611.80M | 14.29% | 852,551 | 45.71M |
| 156 | KURA | Kura Oncology, Inc. | 611.22M | 6.36% | 1,313,666 | - |
| 157 | ABUS | Arbutus Biopharma Corporation | 610.16M | 0.31% | 377,192 | 6.74M |
| 158 | HUMA | Humacyte, Inc. | 590.59M | 0.66% | 1,441,511 | - |
| 159 | CRGX | CARGO Therapeutics, Inc. | 585.47M | -1.09% | 190,697 | - |
| 160 | SVRA | Savara Inc. | 580.21M | -1.07% | 3,248,060 | - |
| 161 | UPB | Upstream Bio, Inc. | 577.24M | -0.37% | 413,767 | 2.21M |
| 162 | AUTL | Autolus Therapeutics plc | 574.82M | -1.37% | 1,332,166 | 10.09M |
| 163 | ERAS | Erasca, Inc. | 545.66M | 1.58% | 814,511 | - |
| 164 | OMER | Omeros Corporation | 538.35M | 1.53% | 439,159 | - |
| 165 | STOK | Stoke Therapeutics, Inc. | 530.73M | 2.24% | 562,644 | 16.74M |
| 166 | MNMD | Mind Medicine (MindMed) Inc. | 513.69M | -2.44% | 1,232,902 | - |
| 167 | MLYS | Mineralys Therapeutics, Inc. | 507.14M | 4.30% | 244,480 | - |
| 168 | RAPP | Rapport Therapeutics, Inc. | 504.02M | 3.84% | 102,134 | - |
| 169 | ALT | Altimmune, Inc. | 493.60M | 1.61% | 1,695,401 | 52.00K |
| 170 | ANAB | AnaptysBio, Inc. | 492.34M | -4.15% | 602,830 | 57.17M |
| 171 | XERS | Xeris Biopharma Holdings, Inc. | 490.48M | -1.50% | 712,869 | 187.36M |
| 172 | RNAC | Cartesian Therapeutics, Inc. | 490.32M | -3.98% | 72,252 | 47.94M |
| 173 | PROK | ProKidney Corp. | 487.08M | -6.70% | 350,675 | - |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 477.96M | 2.95% | 853,083 | 26.27M |
| 175 | MGTX | MeiraGTx Holdings plc | 472.05M | -5.77% | 353,113 | 13.93M |
| 176 | ABSI | Absci Corporation | 462.87M | 25.16% | 22,557,813 | 4.21M |
| 177 | KROS | Keros Therapeutics, Inc. | 461.38M | -0.18% | 2,520,271 | 651.00K |
| 178 | TBPH | Theravance Biopharma, Inc. | 460.27M | 2.30% | 211,411 | 63.19M |
| 179 | GHRS | GH Research PLC | 457.85M | -2.11% | 80,863 | - |
| 180 | ARCT | Arcturus Therapeutics Holdings Inc. | 453.44M | 2.01% | 424,434 | 160.40M |
| 181 | TRML | Tourmaline Bio, Inc. | 452.34M | -1.34% | 172,645 | - |
| 182 | MREO | Mereo BioPharma Group plc | 452.30M | -2.34% | 2,236,572 | 1.00M |
| 183 | TRDA | Entrada Therapeutics, Inc. | 443.98M | -3.98% | 144,518 | 215.23M |
| 184 | ANNX | Annexon, Inc. | 442.36M | -0.48% | 1,222,751 | - |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 435.01M | - | 380,060 | 24.49M |
| 186 | SAGE | Sage Therapeutics, Inc. | 428.82M | 1.01% | 1,259,275 | 106.40M |
| 187 | URGN | UroGen Pharma Ltd. | 424.10M | -1.37% | 356,840 | 89.36M |
| 188 | ATXS | Astria Therapeutics, Inc. | 423.26M | -0.92% | 255,926 | - |
| 189 | KOD | Kodiak Sciences Inc. | 423.16M | 7.47% | 324,535 | - |
| 190 | KALV | KalVista Pharmaceuticals, Inc. | 423.02M | -2.17% | 211,964 | - |
| 191 | OLMA | Olema Pharmaceuticals, Inc. | 421.47M | 3.27% | 497,494 | - |
| 192 | CELC | Celcuity Inc. | 418.45M | 0.54% | 165,775 | - |
| 193 | ABVX | ABIVAX Société Anonyme | 409.12M | -2.20% | 61,926 | 9.68M |
| 194 | PRTC | PureTech Health plc | 406.92M | 0.87% | 563 | 468.00K |
| 195 | PRME | Prime Medicine, Inc. | 405.75M | 9.28% | 1,642,007 | 800.00K |
| 196 | ALLO | Allogene Therapeutics, Inc. | 402.57M | 4.35% | 2,419,568 | 43.00K |
| 197 | TERN | Terns Pharmaceuticals, Inc. | 396.66M | 4.94% | 1,172,025 | - |
| 198 | CDXS | Codexis, Inc. | 396.31M | -3.56% | 428,971 | 64.45M |
| 199 | AURA | Aura Biosciences, Inc. | 396.12M | - | 161,280 | - |
| 200 | RGNX | REGENXBIO Inc. | 388.93M | 3.70% | 1,012,721 | 84.33M |
| 201 | OABI | OmniAb, Inc. | 387.24M | -0.62% | 567,567 | 20.41M |
| 202 | RIGL | Rigel Pharmaceuticals, Inc. | 384.18M | - | 242,199 | 157.37M |
| 203 | RVNC | Revance Therapeutics, Inc. | 383.05M | -0.55% | 3,180,269 | 256.95M |
| 204 | ALMS | Alumis Inc. | 375.41M | -6.88% | 266,026 | - |
| 205 | VALN | Valneva SE | 365.63M | -1.70% | 56,189 | 176.82M |
| 206 | MBX | MBX Biosciences, Inc. | 362.58M | 6.06% | 183,885 | - |
| 207 | KRRO | Korro Bio, Inc. | 357.02M | 1.33% | 54,033 | - |
| 208 | CMPX | Compass Therapeutics, Inc. | 354.98M | -1.15% | 806,088 | 850.00K |
| 209 | ENGN | enGene Holdings Inc. | 354.29M | -0.29% | 27,922 | - |
| 210 | CRVS | Corvus Pharmaceuticals, Inc. | 349.56M | 4.21% | 515,611 | - |
| 211 | ZBIO | Zenas BioPharma, Inc. | 348.12M | -0.83% | 214,161 | - |
| 212 | CMRX | Chimerix, Inc. | 339.96M | -1.56% | 1,536,692 | 159.00K |
| 213 | GLUE | Monte Rosa Therapeutics, Inc. | 339.74M | -2.81% | 551,407 | 14.98M |
| 214 | TRVI | Trevi Therapeutics, Inc. | 337.80M | 6.33% | 530,064 | - |
| 215 | NMRA | Neumora Therapeutics, Inc. | 336.05M | 0.97% | 2,742,285 | - |
| 216 | PGEN | Precigen, Inc. | 330.94M | -4.24% | 1,115,789 | 3.96M |
| 217 | TNGX | Tango Therapeutics, Inc. | 330.85M | - | 951,233 | 43.38M |
| 218 | TSHA | Taysha Gene Therapies, Inc. | 313.56M | - | 1,119,535 | 9.92M |
| 219 | XOMA | XOMA Royalty Corporation | 306.94M | -3.45% | 14,157 | 21.61M |
| 220 | LXRX | Lexicon Pharmaceuticals, Inc. | 303.65M | 6.56% | 10,134,761 | 5.23M |
| 221 | ALDX | Aldeyra Therapeutics, Inc. | 299.53M | 2.86% | 312,185 | - |
| 222 | VYGR | Voyager Therapeutics, Inc. | 296.62M | 4.02% | 268,277 | 163.78M |
| 223 | IMMP | Immutep Limited | 296.48M | 2.62% | 102,639 | 2.56M |
| 224 | ATYR | aTyr Pharma, Inc. | 293.80M | -3.58% | 663,778 | 235.00K |
| 225 | DSGN | Design Therapeutics, Inc. | 293.30M | 6.37% | 224,115 | - |
| 226 | CADL | Candel Therapeutics, Inc. | 290.53M | 3.56% | 823,254 | - |
| 227 | CTNM | Contineum Therapeutics, Inc. | 288.97M | -0.62% | 54,545 | - |
| 228 | ITOS | iTeos Therapeutics, Inc. | 281.68M | -4.34% | 218,929 | 35.00M |
| 229 | DRTS | Alpha Tau Medical Ltd. | 279.72M | -1.48% | 44,246 | - |
| 230 | RZLT | Rezolute, Inc. | 278.71M | -2.24% | 399,060 | - |
| 231 | YMAB | Y-mAbs Therapeutics, Inc. | 277.24M | - | 230,192 | 84.55M |
| 232 | ACIU | AC Immune SA | 268.13M | 2.26% | 112,541 | 48.51M |
| 233 | AVIR | Atea Pharmaceuticals, Inc. | 263.52M | -3.70% | 477,148 | - |
| 234 | THRD | Third Harmonic Bio, Inc. | 263.14M | -2.67% | 321,103 | - |
| 235 | CCCC | C4 Therapeutics, Inc. | 261.89M | -3.64% | 737,771 | 33.67M |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 257.85M | 3.97% | 108,011 | - |
| 237 | SLN | Silence Therapeutics plc | 256.38M | -2.34% | 161,719 | 21.77M |
| 238 | ATAI | Atai Life Sciences N.V. | 255.06M | 1.33% | 805,138 | 331.00K |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 253.64M | -3.55% | 624,998 | 190.86M |
| 240 | VSTM | Verastem, Inc. | 253.50M | 2.41% | 951,659 | 10.00M |
| 241 | NAUT | Nautilus Biotechnology, Inc. | 252.38M | -1.47% | 109,799 | - |
| 242 | ELDN | Eledon Pharmaceuticals, Inc. | 251.50M | 2.93% | 226,373 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 248.18M | -0.74% | 4,991 | - |
| 244 | HRTX | Heron Therapeutics, Inc. | 247.91M | - | 903,684 | 137.74M |
| 245 | FHTX | Foghorn Therapeutics Inc. | 242.94M | -0.91% | 90,410 | 25.52M |
| 246 | CDTX | Cidara Therapeutics, Inc. | 240.55M | -0.86% | 125,049 | 44.65M |
| 247 | SGMO | Sangamo Therapeutics, Inc. | 239.94M | 1.77% | 3,190,016 | 52.29M |
| 248 | NGNE | Neurogene Inc. | 236.93M | -4.03% | 133,486 | 925.00K |
| 249 | AMLX | Amylyx Pharmaceuticals, Inc. | 236.93M | 0.87% | 808,933 | 196.49M |
| 250 | TVGN | Tevogen Bio Holdings Inc. | 236.32M | 4.65% | 1,415,441 | - |
| 251 | CRDF | Cardiff Oncology, Inc. | 235.50M | 0.57% | 1,222,274 | 688.00K |
| 252 | PRQR | ProQR Therapeutics N.V. | 230.66M | 0.22% | 423,417 | 20.51M |
| 253 | DRUG | Bright Minds Biosciences Inc. | 226.30M | -6.03% | 96,511 | - |
| 254 | ABEO | Abeona Therapeutics Inc. | 223.44M | -0.96% | 185,519 | - |
| 255 | LRMR | Larimar Therapeutics, Inc. | 220.77M | 0.87% | 317,689 | - |
| 256 | FULC | Fulcrum Therapeutics, Inc. | 220.61M | 2.25% | 362,837 | 80.87M |
| 257 | OCGN | Ocugen, Inc. | 220.33M | 0.88% | 3,811,988 | 4.70M |
| 258 | FDMT | 4D Molecular Therapeutics, Inc. | 213.11M | -1.28% | 375,722 | 17.00K |
| 259 | CGEN | Compugen Ltd. | 213.10M | 4.85% | 1,371,271 | 59.85M |
| 260 | GOSS | Gossamer Bio, Inc. | 204.40M | -2.17% | 656,451 | 105.32M |
| 261 | SLRN | Acelyrin, Inc. | 202.66M | 1.51% | 1,049,730 | - |
| 262 | HURA | TuHURA Biosciences, Inc. | 200.48M | 0.21% | 110,442 | - |
| 263 | CYBN | Cybin Inc. | 200.01M | 3.95% | 144,104 | - |
| 264 | MDWD | MediWound Ltd. | 198.64M | -0.05% | 64,552 | 19.72M |
| 265 | INBX | Inhibrx Biosciences, Inc. | 196.87M | -4.16% | 34,276 | 1.57M |
| 266 | OBIO | Orchestra BioMed Holdings, Inc. | 196.15M | -0.19% | 60,658 | 2.65M |
| 267 | ACTU | Actuate Therapeutics, Inc. | 195.32M | 5.82% | 57,190 | - |
| 268 | MGNX | MacroGenics, Inc. | 193.31M | 2.67% | 797,747 | 141.33M |
| 269 | IVA | Inventiva S.A. | 190.46M | 0.46% | 3,674 | 20.65M |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 188.14M | -0.36% | 79,658 | 1.00 |
| 271 | MOLN | Molecular Partners AG | 187.26M | -0.96% | 397 | 7.11M |
| 272 | VXRT | Vaxart, Inc. | 185.90M | 6.89% | 1,287,512 | 16.76M |
| 273 | MNPR | Monopar Therapeutics Inc. | 177.70M | 6.28% | 76,451 | - |
| 274 | GNFT | Genfit S.A. | 177.11M | -3.74% | 1,365 | 86.23M |
| 275 | NKTX | Nkarta, Inc. | 175.01M | 1.64% | 915,336 | - |
| 276 | PLX | Protalix BioTherapeutics, Inc. | 174.51M | 1.72% | 464,899 | 45.67M |
| 277 | ACRV | Acrivon Therapeutics, Inc. | 174.36M | -0.89% | 18,997 | - |
| 278 | ALEC | Alector, Inc. | 174.32M | 2.89% | 432,074 | 61.51M |
| 279 | INMB | INmune Bio, Inc. | 170.06M | 17.55% | 744,783 | 42.00K |
| 280 | NKTR | Nektar Therapeutics | 169.33M | 1.55% | 765,908 | 93.14M |
| 281 | LYEL | Lyell Immunopharma, Inc. | 168.14M | 1.16% | 793,316 | 63.00K |
| 282 | GLSI | Greenwich LifeSciences, Inc. | 167.07M | 4.52% | 42,634 | - |
| 283 | RAPT | RAPT Therapeutics, Inc. | 164.65M | 1.67% | 718,879 | - |
| 284 | ADCT | ADC Therapeutics SA | 164.37M | -3.41% | 484,164 | 70.72M |
| 285 | VOR | Vor Biopharma Inc. | 163.15M | -3.68% | 576,559 | - |
| 286 | STRO | Sutro Biopharma, Inc. | 162.44M | -1.01% | 740,661 | 160.96M |
| 287 | LXEO | Lexeo Therapeutics, Inc. | 162.08M | 0.41% | 304,569 | - |
| 288 | ZNTL | Zentalis Pharmaceuticals, Inc. | 161.06M | 0.44% | 2,854,365 | 40.56M |
| 289 | SCPH | scPharmaceuticals Inc. | 160.63M | -0.93% | 275,835 | 30.28M |
| 290 | ARTV | Artiva Biotherapeutics, Inc. | 159.10M | -7.36% | 119,169 | 2.60M |
| 291 | FENC | Fennec Pharmaceuticals Inc. | 157.40M | -0.17% | 76,413 | 49.35M |
| 292 | CLLS | Cellectis S.A. | 157.01M | 1.32% | 219,058 | 36.04M |
| 293 | NBTX | Nanobiotix S.A. | 156.81M | -1.23% | 7,877 | 45.22M |
| 294 | BMEA | Biomea Fusion, Inc. | 156.55M | 1.65% | 498,811 | - |
| 295 | MCRB | Seres Therapeutics, Inc. | 155.63M | 24.69% | 11,347,396 | 126.33M |
| 296 | VTYX | Ventyx Biosciences, Inc. | 152.74M | 3.85% | 1,811,714 | - |
| 297 | FATE | Fate Therapeutics, Inc. | 152.62M | 1.52% | 1,295,743 | 13.45M |
| 298 | IPHA | Innate Pharma S.A. | 152.24M | 0.28% | 2,984 | 36.20M |
| 299 | VERU | Veru Inc. | 152.24M | -4.59% | 3,502,165 | 16.89M |
| 300 | CHRS | Coherus BioSciences, Inc. | 150.93M | -0.76% | 2,882,372 | 304.34M |
| 301 | LCTX | Lineage Cell Therapeutics, Inc. | 148.78M | 15.36% | 2,921,814 | 8.72M |
| 302 | TELO | Telomir Pharmaceuticals, Inc. | 148.17M | 1.01% | 70,690 | - |
| 303 | BDTX | Black Diamond Therapeutics, Inc. | 147.69M | 16.52% | 1,430,846 | - |
| 304 | IFRX | InflaRx N.V. | 147.21M | 1.21% | 228,128 | 187.93K |
| 305 | ADAP | Adaptimmune Therapeutics plc | 147.06M | 0.82% | 688,358 | 175.04M |
| 306 | CSBR | Champions Oncology, Inc. | 146.85M | 1.23% | 29,946 | 53.57M |
| 307 | PBYI | Puma Biotechnology, Inc. | 144.81M | -1.01% | 272,122 | 243.57M |
| 308 | TCRX | TScan Therapeutics, Inc. | 142.39M | 6.33% | 348,216 | 9.36M |
| 309 | KYTX | Kyverna Therapeutics, Inc. | 142.03M | -1.50% | 259,728 | - |
| 310 | SEER | Seer, Inc. | 139.75M | 0.42% | 81,558 | 14.61M |
| 311 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 138.24M | -4.86% | 219,162 | - |
| 312 | CRBU | Caribou Biosciences, Inc. | 137.64M | - | 1,113,298 | 11.48M |
| 313 | SGMT | Sagimet Biosciences Inc. | 136.83M | 2.91% | 1,009,495 | - |
| 314 | CKPT | Checkpoint Therapeutics, Inc. | 135.27M | -7.67% | 1,715,530 | 47.00K |
| 315 | MIST | Milestone Pharmaceuticals Inc. | 131.81M | -7.01% | 1,092,644 | - |
| 316 | TSVT | 2seventy bio, Inc. | 130.00M | 2.86% | 224,617 | 45.62M |
| 317 | TIL | Instil Bio, Inc. | 128.69M | 0.56% | 53,159 | - |
| 318 | RENB | Renovaro Inc. | 126.48M | 11.47% | 1,275,714 | - |
| 319 | CLYM | Climb Bio, Inc. | 125.71M | -0.53% | 258,520 | - |
| 320 | SLDB | Solid Biosciences Inc. | 124.66M | -4.29% | 454,294 | - |
| 321 | SAVA | Cassava Sciences, Inc. | 124.61M | -1.15% | 983,743 | - |
| 322 | CABA | Cabaletta Bio, Inc. | 124.15M | -2.31% | 952,587 | - |
| 323 | ALGS | Aligos Therapeutics, Inc. | 121.96M | -2.75% | 174,171 | 6.00M |
| 324 | ANRO | Alto Neuroscience, Inc. | 121.91M | -4.44% | 255,865 | - |
| 325 | ATOS | Atossa Therapeutics, Inc. | 120.43M | 10.05% | 1,027,481 | - |
| 326 | NVCT | Nuvectis Pharma, Inc. | 117.86M | 6.83% | 40,027 | - |
| 327 | CAMP | Camp4 Therapeutics Corporation | 116.93M | -11.32% | 139,548 | - |
| 328 | ZURA | Zura Bio Limited | 116.88M | - | 298,078 | - |
| 329 | XBIT | XBiotech Inc. | 114.92M | -1.57% | 60,600 | - |
| 330 | MGX | Metagenomi, Inc. | 113.39M | 11.40% | 16,861,380 | 55.08M |
| 331 | EDIT | Editas Medicine, Inc. | 110.61M | 10.74% | 4,507,143 | 61.76M |
| 332 | EPRX | Eupraxia Pharmaceuticals Inc. | 110.24M | -4.38% | 1,586 | - |
| 333 | ENTA | Enanta Pharmaceuticals, Inc. | 109.79M | 1.17% | 485,092 | 67.64M |
| 334 | GNLX | Genelux Corporation | 107.43M | 9.00% | 449,636 | 8.00K |
| 335 | ACHV | Achieve Life Sciences, Inc. | 105.58M | 7.72% | 465,769 | - |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 105.14M | 7.36% | 587,084 | - |
| 337 | FBRX | Forte Biosciences, Inc. | 102.23M | 8.78% | 88,553 | - |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 101.40M | -1.54% | 1,579,500 | - |
| 339 | IGMS | IGM Biosciences, Inc. | 101.09M | -0.58% | 711,686 | 2.92M |
| 340 | ALLK | Allakos Inc. | 100.06M | 0.90% | 539,257 | - |
| 341 | TARA | Protara Therapeutics, Inc. | 96.75M | -1.47% | 103,539 | - |
| 342 | ANIX | Anixa Biosciences, Inc. | 95.78M | 5.87% | 370,483 | - |
| 343 | ASMB | Assembly Biosciences, Inc. | 95.03M | 4.55% | 37,976 | 28.33M |
| 344 | ALXO | ALX Oncology Holdings Inc. | 94.94M | 9.09% | 1,415,783 | - |
| 345 | COYA | Coya Therapeutics, Inc. | 94.56M | - | 7,628 | 9.55M |
| 346 | DBVT | DBV Technologies S.A. | 94.21M | 4.87% | 16,144 | 12.52M |
| 347 | ORMP | Oramed Pharmaceuticals Inc. | 93.12M | 0.43% | 73,782 | - |
| 348 | ADVM | Adverum Biotechnologies, Inc. | 92.99M | 1.59% | 80,393 | 1.00M |
| 349 | PYXS | Pyxis Oncology, Inc. | 92.77M | 1.96% | 517,271 | 16.15M |
| 350 | ENTX | Entera Bio Ltd. | 91.71M | 3.75% | 106,276 | 99.00K |
| 351 | HLVX | HilleVax, Inc. | 91.65M | - | 90,115 | - |
| 352 | GUTS | Fractyl Health, Inc. | 90.43M | 3.58% | 262,203 | 97.00K |
| 353 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 90.36M | -3.00% | 2,313,946 | - |
| 354 | JSPR | Jasper Therapeutics, Inc. | 90.16M | 5.44% | 542,941 | - |
| 355 | MNOV | MediciNova, Inc. | 88.77M | -1.63% | 25,770 | - |
| 356 | IMUX | Immunic, Inc. | 88.60M | 3.54% | 850,760 | - |
| 357 | CBUS | Cibus, Inc. | 88.16M | 11.11% | 209,398 | 4.15M |
| 358 | LPTX | Leap Therapeutics, Inc. | 88.13M | -6.50% | 1,665,685 | - |
| 359 | IMAB | I-Mab | 87.21M | -1.83% | 246,429 | 3.31M |
| 360 | TLSA | Tiziana Life Sciences Ltd | 86.93M | 8.51% | 2,940,094 | - |
| 361 | AGEN | Agenus Inc. | 85.86M | -4.44% | 1,110,517 | 160.43M |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 85.57M | 5.67% | 236,804 | - |
| 363 | KPTI | Karyopharm Therapeutics Inc. | 84.09M | -2.98% | 1,447,718 | 148.44M |
| 364 | INZY | Inozyme Pharma, Inc. | 83.51M | -3.70% | 980,583 | - |
| 365 | VTGN | Vistagen Therapeutics, Inc. | 83.25M | -0.66% | 131,594 | 876.00K |
| 366 | XFOR | X4 Pharmaceuticals, Inc. | 83.21M | -0.29% | 1,173,688 | 1.12M |
| 367 | VIGL | Vigil Neuroscience, Inc. | 82.89M | -2.40% | 123,895 | - |
| 368 | NTRB | Nutriband Inc. | 81.52M | 40.88% | 4,313,182 | 2.02M |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 81.22M | 2.27% | 709,897 | 203.41K |
| 370 | RGLS | Regulus Therapeutics Inc. | 81.22M | -1.59% | 218,844 | - |
| 371 | ELTX | Elicio Therapeutics, Inc. | 80.50M | 15.81% | 65,827 | - |
| 372 | SLS | SELLAS Life Sciences Group, Inc. | 80.24M | -0.87% | 1,453,394 | - |
| 373 | ADAG | Adagene Inc. | 79.69M | - | 11,603 | 815.75K |
| 374 | ARMP | Armata Pharmaceuticals, Inc. | 79.24M | -2.23% | 11,114 | 5.47M |
| 375 | THTX | Theratechnologies Inc. | 78.98M | -3.11% | 36,045 | 84.32M |
| 376 | SKYE | Skye Bioscience, Inc. | 78.58M | -4.07% | 60,516 | - |
| 377 | ANL | Adlai Nortye Ltd. | 76.84M | 1.09% | 1,953 | 5.00M |
| 378 | CUE | Cue Biopharma, Inc. | 76.65M | - | 461,372 | 9.53M |
| 379 | BLUE | bluebird bio, Inc. | 76.22M | -3.69% | 283,694 | 53.12M |
| 380 | OKUR | OnKure Therapeutics, Inc. | 76.03M | -3.39% | 115,490 | - |
| 381 | GALT | Galectin Therapeutics Inc. | 75.94M | -1.63% | 185,555 | - |
| 382 | EPIX | ESSA Pharma Inc. | 75.90M | -1.72% | 230,970 | - |
| 383 | IPSC | Century Therapeutics, Inc. | 75.76M | -0.69% | 291,143 | 2.68M |
| 384 | ACET | Adicet Bio, Inc. | 75.64M | -2.23% | 143,860 | - |
| 385 | AADI | Aadi Bioscience, Inc. | 73.70M | -0.99% | 92,395 | 25.07M |
| 386 | ANVS | Annovis Bio, Inc. | 73.26M | 1.72% | 218,827 | - |
| 387 | APLT | Applied Therapeutics, Inc. | 73.12M | -4.09% | 4,141,042 | -212.00K |
| 388 | AVTE | Aerovate Therapeutics, Inc. | 73.05M | -0.78% | 152,097 | - |
| 389 | GNTA | Genenta Science S.p.A. | 72.98M | 1.79% | 3,343 | - |
| 390 | CLSD | Clearside Biomedical, Inc. | 72.42M | 3.55% | 195,166 | 7.70M |
| 391 | VANI | Vivani Medical, Inc. | 72.27M | 1.67% | 74,326 | - |
| 392 | IKNA | Ikena Oncology, Inc. | 70.94M | -3.29% | 121,217 | 659.00K |
| 393 | BYSI | BeyondSpring Inc. | 70.53M | -0.85% | 23,674 | 1.88M |
| 394 | CNTX | Context Therapeutics Inc. | 70.33M | -3.74% | 111,609 | - |
| 395 | AVTX | Avalo Therapeutics, Inc. | 68.96M | -4.77% | 11,045 | 820.00K |
| 396 | QNCX | Quince Therapeutics, Inc. | 68.64M | 5.41% | 178,687 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 68.31M | -2.22% | 675,675 | - |
| 398 | ABP | Abpro Holdings, Inc. | 68.21M | 2.27% | 39,470 | 72.00K |
| 399 | MURA | Mural Oncology plc | 67.47M | -4.59% | 157,198 | - |
| 400 | ONCY | Oncolytics Biotech Inc. | 67.00M | 5.26% | 3,413,858 | - |
| 401 | CTMX | CytomX Therapeutics, Inc. | 65.57M | -3.82% | 505,763 | 126.62M |
| 402 | IMRX | Immuneering Corporation | 65.52M | -0.47% | 486,816 | - |
| 403 | MRSN | Mersana Therapeutics, Inc. | 65.16M | -4.07% | 8,604,401 | 34.84M |
| 404 | VRCA | Verrica Pharmaceuticals Inc. | 64.87M | 0.60% | 298,433 | 9.21M |
| 405 | UNCY | Unicycive Therapeutics, Inc. | 64.76M | -4.56% | 608,276 | - |
| 406 | PEPG | PepGen Inc. | 64.54M | -4.58% | 470,854 | - |
| 407 | PRLD | Prelude Therapeutics Incorporated | 64.39M | -4.10% | 333,592 | 3.00M |
| 408 | OSTX | OS Therapies Incorporated | 64.35M | -2.88% | 231,447 | - |
| 409 | GBIO | Generation Bio Co. | 63.83M | -3.45% | 376,386 | 18.58M |
| 410 | PDSB | PDS Biotechnology Corporation | 62.85M | 12.75% | 518,108 | - |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 60.61M | - | 190,018 | 3.39M |
| 412 | KRON | Kronos Bio, Inc. | 60.34M | 0.99% | 375,652 | 9.86M |
| 413 | TNXP | Tonix Pharmaceuticals Holding Corp. | 59.62M | 33.53% | 203,714,187 | 11.29M |
| 414 | IOBT | IO Biotech, Inc. | 59.30M | 3.25% | 110,777 | - |
| 415 | FBLG | FibroBiologics, Inc. | 59.29M | -3.98% | 107,616 | - |
| 416 | BOLD | Boundless Bio, Inc. | 57.31M | - | 45,094 | - |
| 417 | GANX | Gain Therapeutics, Inc. | 56.50M | -2.29% | 118,653 | - |
| 418 | CNTB | Connect Biopharma Holdings Limited | 56.36M | -4.67% | 3,672 | 24.12M |
| 419 | IMMX | Immix Biopharma, Inc. | 54.47M | 0.51% | 73,485 | - |
| 420 | STTK | Shattuck Labs, Inc. | 53.47M | -2.61% | 86,761 | 6.44M |
| 421 | CELU | Celularity Inc. | 52.16M | 0.43% | 111,488 | 48.20M |
| 422 | OTLK | Outlook Therapeutics, Inc. | 52.05M | -8.93% | 1,147,462 | - |
| 423 | RPTX | Repare Therapeutics Inc. | 51.44M | -2.42% | 291,188 | 66.52M |
| 424 | FGEN | FibroGen, Inc. | 50.79M | -4.92% | 2,470,067 | 180.02M |
| 425 | FBIO | Fortress Biotech, Inc. | 49.96M | -2.69% | 470,054 | 81.50M |
| 426 | OVID | Ovid Therapeutics Inc. | 49.92M | 0.69% | 620,035 | 631.70K |
| 427 | MAIA | MAIA Biotechnology, Inc. | 49.40M | - | 117,039 | - |
| 428 | LSB | LakeShore Biopharma Co., Ltd | 48.66M | 1.19% | 6,154 | 79.42M |
| 429 | IVVD | Invivyd, Inc. | 48.64M | -0.22% | 332,408 | 11.56M |
| 430 | LTRN | Lantern Pharma Inc. | 48.32M | 9.80% | 111,437 | - |
| 431 | SPRO | Spero Therapeutics, Inc. | 47.65M | -2.41% | 186,456 | 106.46M |
| 432 | ACHL | Achilles Therapeutics plc | 47.27M | - | 109,125 | - |
| 433 | KZR | Kezar Life Sciences, Inc. | 46.70M | 1.11% | 36,010 | - |
| 434 | DYAI | Dyadic International, Inc. | 46.16M | - | 23,066 | 3.36M |
| 435 | CLGN | CollPlant Biotechnologies Ltd. | 45.88M | 0.13% | 10,306 | 650.00K |
| 436 | ALVR | AlloVir, Inc. | 45.78M | -1.92% | 38,133 | - |
| 437 | ICCC | ImmuCell Corporation | 45.54M | -5.02% | 7,599 | 23.84M |
| 438 | SER | Serina Therapeutics, Inc. | 44.71M | -3.25% | 13,149 | 3.16M |
| 439 | VTVT | vTv Therapeutics Inc. | 43.00M | -3.44% | 4,495 | 1.00M |
| 440 | BRNS | Barinthus Biotherapeutics plc | 42.24M | 9.38% | 22,831 | 14.97M |
| 441 | NRXP | NRx Pharmaceuticals, Inc. | 41.97M | -1.42% | 529,678 | - |
| 442 | QTTB | Q32 Bio Inc. | 41.90M | 1.18% | 101,341 | -14.66M |
| 443 | ITRM | Iterum Therapeutics plc | 41.82M | - | 406,641 | - |
| 444 | ANEB | Anebulo Pharmaceuticals, Inc. | 41.76M | 1.26% | 6,265 | - |
| 445 | ESLA | Estrella Immunopharma, Inc. | 41.24M | -1.72% | 8,158 | - |
| 446 | ATNM | Actinium Pharmaceuticals, Inc. | 41.18M | 1.54% | 123,552 | 81.00K |
| 447 | VYNE | VYNE Therapeutics Inc. | 40.12M | -1.81% | 55,672 | 493.00K |
| 448 | CASI | CASI Pharmaceuticals, Inc. | 39.97M | -2.64% | 43,847 | 22.06M |
| 449 | INKT | MiNK Therapeutics, Inc. | 39.95M | 6.32% | 413,341 | - |
| 450 | ATRA | Atara Biotherapeutics, Inc. | 39.68M | 13.88% | 497,859 | 100.44M |
| 451 | GRCE | Grace Therapeutics, Inc. | 39.65M | 3.99% | 76,977 | - |
| 452 | CALC | CalciMedica, Inc. | 39.64M | -5.16% | 23,087 | - |
| 453 | ELEV | Elevation Oncology, Inc. | 39.61M | -5.85% | 1,772,329 | - |
| 454 | CMMB | Chemomab Therapeutics Ltd. | 39.41M | -0.48% | 109,233 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 39.13M | -29.91% | 2,412,882 | 4.62M |
| 456 | TPST | Tempest Therapeutics, Inc. | 38.53M | -0.42% | 740,949 | - |
| 457 | INTS | Intensity Therapeutics, Inc. | 38.51M | -1.35% | 40,345 | - |
| 458 | DTIL | Precision BioSciences, Inc. | 38.13M | 8.99% | 261,041 | 75.10M |
| 459 | SRZN | Surrozen, Inc. | 38.02M | -7.29% | 30,616 | 10.00M |
| 460 | ANTX | AN2 Therapeutics, Inc. | 37.65M | -0.79% | 156,675 | - |
| 461 | PASG | Passage Bio, Inc. | 36.81M | -3.42% | 88,256 | - |
| 462 | RADX | Radiopharm Theranostics Limited | 36.77M | -7.55% | 332,030 | 1.31M |
| 463 | RLYB | Rallybio Corporation | 36.19M | -2.44% | 24,597 | 598.00K |
| 464 | RNXT | RenovoRx, Inc. | 35.50M | -3.90% | 84,696 | - |
| 465 | BIVI | BioVie Inc. | 35.48M | -2.44% | 605,596 | - |
| 466 | CVKD | Cadrenal Therapeutics, Inc. | 35.45M | 14.31% | 124,956 | - |
| 467 | KALA | KALA BIO, Inc. | 35.45M | 0.13% | 75,965 | - |
| 468 | UBX | Unity Biotechnology, Inc. | 35.22M | 16.76% | 525,103 | - |
| 469 | OKYO | OKYO Pharma Limited | 35.06M | -2.24% | 37,554 | - |
| 470 | LEXX | Lexaria Bioscience Corp. | 34.75M | 2.06% | 248,717 | 496.92K |
| 471 | SABS | SAB Biotherapeutics, Inc. | 34.33M | 1.36% | 25,048 | 1.51M |
| 472 | IRD | Opus Genetics, Inc. | 34.09M | -6.09% | 124,513 | 8.38M |
| 473 | ERNA | Eterna Therapeutics Inc. | 32.63M | 35.44% | 12,217,614 | 598.00K |
| 474 | CGTX | Cognition Therapeutics, Inc. | 31.96M | 3.96% | 917,251 | - |
| 475 | XCUR | Exicure, Inc. | 31.51M | -15.07% | 338,555 | 500.00K |
| 476 | RAIN | Rain Enhancement Technologies Holdco, Inc. | 31.41M | -1.14% | 3,050 | - |
| 477 | MLEC | Moolec Science SA | 31.33M | 4.82% | 2,338 | 5.63M |
| 478 | AKTX | Akari Therapeutics, Plc | 31.20M | -1.56% | 28,568 | - |
| 479 | PMN | ProMIS Neurosciences, Inc. | 30.51M | -4.76% | 23,063 | - |
| 480 | CVM | CEL-SCI Corporation | 30.14M | 3.30% | 481,039 | - |
| 481 | MRNS | Marinus Pharmaceuticals, Inc. | 30.08M | 0.55% | 2,365,395 | 31.47M |
| 482 | GDTC | CytoMed Therapeutics Limited | 29.43M | 3.66% | 66,819 | 330.25K |
| 483 | BCAB | BioAtla, Inc. | 28.93M | -1.29% | 615,702 | 11.00M |
| 484 | DARE | Daré Bioscience, Inc. | 28.54M | -1.50% | 10,126 | 1.88M |
| 485 | ATHE | Alterity Therapeutics Limited | 28.34M | -6.02% | 20,442 | 2.68M |
| 486 | IBIO | iBio, Inc. | 28.09M | 5.14% | 1,195,032 | 175.00K |
| 487 | CRIS | Curis, Inc. | 27.69M | -4.66% | 38,990 | 10.26M |
| 488 | IGC | IGC Pharma, Inc. | 27.49M | 5.42% | 419,380 | 1.18M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 27.07M | -3.08% | 74,667 | - |
| 490 | OMGA | Omega Therapeutics, Inc. | 26.30M | -5.00% | 418,550 | 8.10M |
| 491 | ENLV | Enlivex Therapeutics Ltd. | 26.17M | - | 30,079 | - |
| 492 | NRXS | NeurAxis, Inc. | 25.88M | 0.35% | 17,968 | 2.46M |
| 493 | LGVN | Longeveron Inc. | 25.52M | -2.82% | 152,441 | 1.85M |
| 494 | CDIO | Cardio Diagnostics Holdings, Inc. | 25.35M | 3.11% | 34,947,675 | 35.69K |
| 495 | NRSN | NeuroSense Therapeutics Ltd. | 25.21M | -3.54% | 119,887 | - |
| 496 | SLGL | Sol-Gel Technologies Ltd. | 25.04M | 0.07% | 102,710 | 11.71M |
| 497 | LVTX | LAVA Therapeutics N.V. | 24.81M | -0.71% | 12,226 | 7.35M |
| 498 | HOOK | HOOKIPA Pharma Inc. | 23.99M | -2.45% | 43,878 | 50.00M |
| 499 | LPCN | Lipocine Inc. | 23.48M | -6.60% | 28,998 | 7.92M |
| 500 | PLUR | Pluri Inc. | 23.47M | -2.54% | 13,157 | 598.00K |
| 501 | MRKR | Marker Therapeutics, Inc. | 23.13M | 5.37% | 76,760 | 5.40M |
| 502 | LSTA | Lisata Therapeutics, Inc. | 23.09M | -29.49% | 379,583 | - |
| 503 | EQ | Equillium, Inc. | 22.32M | -1.56% | 96,973 | 45.91M |
| 504 | PULM | Pulmatrix, Inc. | 22.32M | 0.49% | 5,376 | 10.01M |
| 505 | NXTC | NextCure, Inc. | 22.31M | -1.39% | 25,726 | - |
| 506 | COEP | Coeptis Therapeutics Holdings, Inc. | 22.20M | 13.56% | 57,981 | - |
| 507 | TENX | Tenax Therapeutics, Inc. | 22.16M | 0.93% | 9,560 | - |
| 508 | PTN | Palatin Technologies, Inc. | 22.05M | -14.55% | 495,885 | 2.38M |
| 509 | PYPD | PolyPid Ltd. | 22.04M | 0.31% | 22,402 | - |
| 510 | CARA | Cara Therapeutics, Inc. | 21.85M | 3.91% | 32,952 | 8.69M |
| 511 | APRE | Aprea Therapeutics, Inc. | 21.79M | -0.99% | 33,123 | 1.31M |
| 512 | BLRX | BioLineRx Ltd. | 21.74M | 6.10% | 5,091,742 | 21.99M |
| 513 | IPA | ImmunoPrecise Antibodies Ltd. | 21.61M | 30.73% | 326,370,355 | 17.27M |
| 514 | ATHA | Athira Pharma, Inc. | 21.26M | 1.93% | 91,168 | - |
| 515 | SNTI | Senti Biosciences, Inc. | 20.97M | 2.24% | 52,102 | - |
| 516 | KAPA | Kairos Pharma, Ltd. | 20.94M | 2.52% | 241,326 | - |
| 517 | COCP | Cocrystal Pharma, Inc. | 20.35M | 2.56% | 44,715 | - |
| 518 | BOLT | Bolt Biotherapeutics, Inc. | 20.28M | 0.19% | 100,953 | 9.78M |
| 519 | GOVX | GeoVax Labs, Inc. | 19.91M | -4.96% | 488,861 | 3.09M |
| 520 | INAB | IN8bio, Inc. | 18.68M | -9.90% | 729,175 | - |
| 521 | MEIP | MEI Pharma, Inc. | 18.46M | -2.12% | 9,682 | - |
| 522 | CARM | Carisma Therapeutics, Inc. | 18.38M | -4.30% | 162,859 | 20.27M |
| 523 | NKGN | NKGen Biotech, Inc. | 18.30M | 5.96% | 306,948 | - |
| 524 | BCTX | BriaCell Therapeutics Corp. | 18.14M | 3.05% | 362,452 | - |
| 525 | BTAI | BioXcel Therapeutics, Inc. | 18.04M | 1.54% | 3,123,306 | 2.28M |
| 526 | AFMD | Affimed N.V. | 18.03M | -3.51% | 149,366 | 6.29M |
| 527 | CRVO | CervoMed Inc. | 17.99M | - | 154,418 | 10.07M |
| 528 | IBO | Impact BioMedical Inc. | 17.95M | 5.41% | 8,840 | - |
| 529 | TRAW | Traws Pharma, Inc. | 17.31M | 3.81% | 81,928 | 226.00K |
| 530 | NNVC | NanoViricides, Inc. | 17.07M | 6.25% | 171,041 | - |
| 531 | SYBX | Synlogic, Inc. | 16.73M | -1.38% | 23,944 | 2.78M |
| 532 | GLYC | GlycoMimetics, Inc. | 16.57M | -2.24% | 186,677 | 10.00K |
| 533 | CHRO | Channel Therapeutics Corporation | 16.28M | 4.89% | 915,446 | - |
| 534 | OCEA | Ocean Biomedical, Inc. | 16.21M | -3.13% | 169,648 | - |
| 535 | MTVA | MetaVia Inc. | 16.20M | -2.59% | 31,752 | - |
| 536 | CING | Cingulate Inc. | 16.16M | 4.36% | 93,550 | - |
| 537 | CANF | Can-Fite BioPharma Ltd. | 16.09M | -2.53% | 70,783 | 667.00K |
| 538 | BRTX | BioRestorative Therapies, Inc. | 16.02M | 9.20% | 163,128 | 377.00K |
| 539 | SPRB | Spruce Biosciences, Inc. | 15.59M | 0.99% | 318,278 | 7.10M |
| 540 | XTLB | XTL Biopharmaceuticals Ltd. | 15.21M | 6.94% | 1,382 | 46.00K |
| 541 | HCWB | HCW Biologics Inc. | 15.14M | -2.86% | 95,111 | 3.50M |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 14.76M | -8.46% | 1,913,304 | - |
| 543 | NERV | Minerva Neurosciences, Inc. | 14.76M | -3.43% | 71,849 | - |
| 544 | AIM | AIM ImmunoTech Inc. | 14.35M | 4.88% | 1,436,363 | 190.00K |
| 545 | ACXP | Acurx Pharmaceuticals, Inc. | 14.33M | -4.71% | 205,641 | - |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 13.74M | 3.06% | 176,428 | - |
| 547 | INDP | Indaptus Therapeutics, Inc. | 13.42M | 7.95% | 25,689 | - |
| 548 | PHGE | BiomX Inc. | 13.35M | -3.89% | 22,993 | - |
| 549 | IMNN | Imunon, Inc. | 12.91M | -0.70% | 121,395 | - |
| 550 | LYRA | Lyra Therapeutics, Inc. | 12.61M | 0.05% | 497,889 | 1.47M |
| 551 | APTO | Aptose Biosciences Inc. | 12.42M | -4.04% | 382,362 | - |
| 552 | IMRN | Immuron Limited | 12.35M | -4.42% | 3,551 | 3.27M |
| 553 | EVGN | Evogene Ltd. | 12.19M | -2.17% | 29,969 | 7.48M |
| 554 | BCLI | Brainstorm Cell Therapeutics Inc. | 12.15M | -7.39% | 38,696 | - |
| 555 | RLMD | Relmada Therapeutics, Inc. | 11.76M | 5.07% | 435,622 | - |
| 556 | KPRX | Kiora Pharmaceuticals, Inc. | 11.61M | -3.25% | 30,823 | 16.02M |
| 557 | PMCB | PharmaCyte Biotech, Inc. | 11.57M | -0.60% | 7,014 | - |
| 558 | ENSC | Ensysce Biosciences, Inc. | 10.80M | 3.50% | 421,800 | 4.42M |
| 559 | APLM | Apollomics, Inc. | 10.70M | -2.90% | 1,103 | 2.10M |
| 560 | CSCI | COSCIENS Biopharma Inc. | 10.53M | -6.35% | 3,416 | 4.83M |
| 561 | CLRB | Cellectar Biosciences, Inc. | 10.19M | -0.60% | 891,625 | - |
| 562 | TSBX | Turnstone Biologics Corp. | 9.95M | -6.52% | 64,613 | - |
| 563 | JAGX | Jaguar Health, Inc. | 9.81M | -1.06% | 248,017 | 10.48M |
| 564 | BCDA | BioCardia, Inc. | 9.63M | -3.23% | 19,647 | 71.00K |
| 565 | HOTH | Hoth Therapeutics, Inc. | 9.39M | -4.23% | 1,068,184 | - |
| 566 | KLTO | Klotho Neurosciences, Inc. | 9.38M | -1.56% | 85,421 | - |
| 567 | PPBT | Purple Biotech Ltd | 9.36M | -2.26% | 29,233 | - |
| 568 | VRAX | Virax Biolabs Group Limited | 9.29M | 2.39% | 96,438 | 84.87K |
| 569 | MBIO | Mustang Bio, Inc. | 8.92M | -3.70% | 170,209 | - |
| 570 | DOMH | Dominari Holdings Inc. | 8.47M | -2.17% | 30,451 | 12.59M |
| 571 | SILO | Silo Pharma, Inc. | 8.39M | -3.61% | 956,906 | 72.10K |
| 572 | CDT | Conduit Pharmaceuticals Inc. | 7.49M | -7.41% | 72,089,501 | - |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 7.47M | 1.72% | 22,964 | 194.00K |
| 574 | ICU | SeaStar Medical Holding Corporation | 7.36M | -5.71% | 237,017 | 68.00K |
| 575 | GLTO | Galecto, Inc. | 7.24M | -4.01% | 16,110 | - |
| 576 | PSTV | Plus Therapeutics, Inc. | 7.19M | -1.61% | 7,384 | 5.73M |
| 577 | ADXN | Addex Therapeutics Ltd | 6.72M | 0.26% | 6,229 | 701.26K |
| 578 | XBIO | Xenetic Biosciences, Inc. | 6.66M | 3.35% | 5,867 | 2.52M |
| 579 | VIRX | Viracta Therapeutics, Inc. | 6.48M | -2.16% | 259,535 | - |
| 580 | ALZN | Alzamend Neuro, Inc. | 6.41M | -0.84% | 59,317 | - |
| 581 | PHIO | Phio Pharmaceuticals Corp. | 6.40M | -7.66% | 951,245 | - |
| 582 | GNPX | Genprex, Inc. | 6.40M | 8.17% | 151,173 | - |
| 583 | ABVC | ABVC BioPharma, Inc. | 6.37M | -4.64% | 111,140 | 509.79K |
| 584 | APM | Aptorum Group Limited | 6.28M | 0.90% | 128,401 | - |
| 585 | PLRZ | Polyrizon Ltd. | 6.21M | 2.07% | 112,403 | - |
| 586 | EYEN | Eyenovia, Inc. | 6.18M | -7.50% | 12,275,318 | 31.83K |
| 587 | ELAB | PMGC Holdings Inc. | 6.18M | -4.74% | 123,466 | 2.45M |
| 588 | ADIL | Adial Pharmaceuticals, Inc. | 6.18M | -0.87% | 52,269 | - |
| 589 | SNGX | Soligenix, Inc. | 6.17M | 2.50% | 103,712 | 364.18K |
| 590 | EDSA | Edesa Biotech, Inc. | 6.10M | 0.57% | 8,217 | - |
| 591 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 6.01M | 29.87% | 752,361 | 18.63K |
| 592 | GRI | GRI Bio, Inc. | 6.00M | -3.31% | 138,914 | - |
| 593 | KZIA | Kazia Therapeutics Limited | 5.97M | -4.86% | 37,046 | 1.66M |
| 594 | CNSP | CNS Pharmaceuticals, Inc. | 5.92M | -2.46% | 7,617,593 | - |
| 595 | CMND | Clearmind Medicine Inc. | 5.88M | 0.69% | 126,327 | - |
| 596 | SYRS | Syros Pharmaceuticals, Inc. | 5.51M | -1.67% | 570,322 | 386.00K |
| 597 | ONVO | Organovo Holdings, Inc. | 5.49M | -6.93% | 121,344 | 103.00K |
| 598 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.38M | 1.27% | 4,733 | - |
| 599 | GTBP | GT Biopharma, Inc. | 5.30M | 2.60% | 29,586 | - |
| 600 | MBRX | Moleculin Biotech, Inc. | 5.25M | -2.78% | 14,387 | - |
| 601 | PBM | Psyence Biomedical Ltd. | 5.07M | -2.91% | 56,661 | - |
| 602 | AEON | AEON Biopharma, Inc. | 4.98M | -6.66% | 9,065,615 | - |
| 603 | PRTG | Portage Biotech Inc. | 4.60M | -0.24% | 5,127 | - |
| 604 | SNPX | Synaptogenix, Inc. | 4.51M | -0.32% | 6,364 | - |
| 605 | ALLR | Allarity Therapeutics, Inc. | 4.48M | -3.81% | 344,103 | - |
| 606 | NCNA | NuCana plc | 4.36M | -3.48% | 19,634 | - |
| 607 | CELZ | Creative Medical Technology Holdings, Inc. | 4.30M | 6.49% | 28,545 | 11.00K |
| 608 | GLMD | Galmed Pharmaceuticals Ltd. | 4.29M | -0.35% | 4,958 | - |
| 609 | CERO | CERo Therapeutics Holdings, Inc. | 4.28M | -3.46% | 193,849 | - |
| 610 | ONCO | Onconetix, Inc. | 4.06M | -9.31% | 445,093 | 1.87M |
| 611 | TOVX | Theriva Biologics, Inc. | 4.01M | -4.64% | 49,866 | - |
| 612 | NBY | NovaBay Pharmaceuticals, Inc. | 3.96M | 13.89% | 432,728 | 13.84M |
| 613 | ARTL | Artelo Biosciences, Inc. | 3.87M | -0.83% | 13,319 | - |
| 614 | SLRX | Salarius Pharmaceuticals, Inc. | 3.86M | 8.06% | 160,173 | - |
| 615 | BPTH | Bio-Path Holdings, Inc. | 3.75M | 3.29% | 97,777 | - |
| 616 | VINC | Vincerx Pharma, Inc. | 3.74M | -24.47% | 8,426,035 | - |
| 617 | DWTX | Dogwood Therapeutics, Inc. | 3.73M | -11.11% | 644,485 | - |
| 618 | LIPO | Lipella Pharmaceuticals Inc. | 3.45M | -0.35% | 11,568 | 483.53K |
| 619 | OGEN | Oragenics, Inc. | 3.42M | -2.78% | 187,665 | - |
| 620 | XRTX | XORTX Therapeutics Inc. | 3.40M | -1.44% | 20,535 | - |
| 621 | ATXI | Avenue Therapeutics, Inc. | 3.31M | -6.49% | 58,706 | - |
| 622 | ENVB | Enveric Biosciences, Inc. | 3.29M | -1.93% | 329,896 | - |
| 623 | ZVSA | ZyVersa Therapeutics, Inc. | 3.28M | -5.41% | 121,213 | - |
| 624 | TNFA | TNF Pharmaceuticals, Inc. | 3.14M | -2.98% | 69,263 | - |
| 625 | TTNP | Titan Pharmaceuticals, Inc. | 3.11M | -2.16% | 21,542 | - |
| 626 | QLGN | Qualigen Therapeutics, Inc. | 3.10M | -0.94% | 7,058 | - |
| 627 | NLSP | NLS Pharmaceutics AG | 3.07M | -0.53% | 76,188 | - |
| 628 | KTTA | Pasithea Therapeutics Corp. | 3.06M | -3.59% | 9,067 | - |
| 629 | SCNI | Scinai Immunotherapeutics Ltd. | 3.05M | 1.52% | 6,036 | 452.00K |
| 630 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.98M | -3.97% | 238,787 | - |
| 631 | THAR | Tharimmune, Inc. | 2.97M | -3.85% | 103,948 | - |
| 632 | TCBP | TC Biopharm (Holdings) Plc | 2.96M | -1.39% | 132,588 | - |
| 633 | MTNB | Matinas BioPharma Holdings, Inc. | 2.92M | -1.07% | 94,983 | - |
| 634 | ATNF | 180 Life Sciences Corp. | 2.91M | -3.29% | 106,152 | - |
| 635 | INM | InMed Pharmaceuticals Inc. | 2.87M | -20.79% | 616,148 | 4.96M |
| 636 | EVAX | Evaxion Biotech A/S | 2.79M | -12.18% | 199,240 | 3.30M |
| 637 | PTIX | Protagenic Therapeutics, Inc. | 2.78M | 1.11% | 43,368 | - |
| 638 | TCRT | Alaunos Therapeutics, Inc. | 2.74M | -3.39% | 4,965 | 7.00K |
| 639 | ENTO | Entero Therapeutics, Inc. | 2.42M | -6.59% | 23,590 | - |
| 640 | BDRX | Biodexa Pharmaceuticals Plc | 2.42M | -3.70% | 5,521 | 104.90K |
| 641 | PCSA | Processa Pharmaceuticals, Inc. | 2.29M | -3.58% | 28,950 | - |
| 642 | APVO | Aptevo Therapeutics Inc. | 2.25M | - | 44,790 | - |
| 643 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.22M | -1.89% | 152,755 | 74.00K |
| 644 | DRMA | Dermata Therapeutics, Inc. | 2.16M | -16.54% | 619,684 | - |
| 645 | SPRC | SciSparc Ltd. | 2.09M | 8.06% | 1,713,977 | 1.75M |
| 646 | AZTR | Azitra, Inc. | 2.04M | 7.27% | 3,628,800 | 97.50K |
| 647 | PALI | Palisade Bio, Inc. | 1.90M | -5.30% | 297,908 | - |
| 648 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.88M | -3.29% | 214,406 | 462.61K |
| 649 | RNAZ | TransCode Therapeutics, Inc. | 1.83M | -0.85% | 35,587 | - |
| 650 | WINT | Windtree Therapeutics, Inc. | 1.81M | -4.42% | 1,893,411 | - |
| 651 | ADTX | Aditxt, Inc. | 1.64M | -5.82% | 11,115,637 | 212.11K |
| 652 | REVB | Revelation Biosciences, Inc. | 1.50M | -15.65% | 890,424 | - |
| 653 | VRPX | Virpax Pharmaceuticals, Inc. | 1.39M | -3.27% | 265,775 | - |
| 654 | SCPX | Scorpius Holdings, Inc. | 1.20M | -8.61% | 1,007,905 | 10.04M |
| 655 | SLXN | Silexion Therapeutics Corp | 1.19M | -3.68% | 492,891 | - |
| 656 | HEPA | Hepion Pharmaceuticals, Inc. | 939.38K | -58.05% | 34,460,562 | - |